for an increased level of production and the Company’s aggressive growth from 2018 onwards; 3) cost from trial runs and start-up of a new production line for some products, driving higher yield loss and
) increased substantially by 25% yoy. EBITDA margin rose from 23% of hospital revenue in 2Q’18 to 26% in 2Q’19. The promising EBITDA was attributable to not only the revenue growth but also the effective cost
prepare for an increased level of production and the Company’s growth from 2018 onwards; 3) cost from trial runs and start-up of a new production line for some products, driving higher yield loss and cost
was lower than the growth rate of services cost. 1.2.2 Administrative Expenses In 2017, administrative expenses was of Bt583.8 million, increasing by Bt5.2 million or 0.9%(y-o-y), mainly due to an
2019 which was mainly due to (1) change in sales mix with more contribution from brands with higher food cost (2) negative same-store sales growth and (3) increased cost of branch staff, rental and
profit is consistent with the increase in the growth of revenue from expansion of business of the company. However, the Gross profit margin has slightly decreased due to cost of program right growth
profit is consistent with the increase in the growth of revenue from expansion of business of the company. However, the Gross profit margin has slightly decreased due to cost of program right growth
per 1 Dollar in Quarter 3 2019. Nevertheless, the Company could maintain the growth rate of revenue of 18%. Cost of Sales and Services In the three-month period ended 30 September 2019 and 2018, total
showed a positive growth of 5% YoY and 6% YoY respectively, whereas its respective cost showed a slower growth of 2% YoY and 5% YoY. Costs of food and beverage were in line with revenues from food and
flat QoQ. Average cost of borrowing was maintained at 3.1% per year. Profit In 2Q18, EBITDA continued to improve 11% YoY and 0.5% QoQ to stand to Bt18,998mn, following revenue growth and continuous cost